2xxh
From Proteopedia
(Difference between revisions)
(6 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | == | + | |
- | <StructureSection load='2xxh' size='340' side='right' caption='[[2xxh]], [[Resolution|resolution]] 1.50Å' scene=''> | + | ==Crystal structure of 1-(4-(2-oxo-2-(1-pyrrolidinyl)ethyl)phenyl)-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 1.5A resolution.== |
+ | <StructureSection load='2xxh' size='340' side='right'caption='[[2xxh]], [[Resolution|resolution]] 1.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[2xxh]] is a 3 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2xxh]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XXH OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2XXH FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1NG:1-{4-[2-OXO-2-(1-PYRROLIDINYL)ETHYL]PHENYL}-3-(+TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOLE'>1NG</scene>, <scene name='pdbligand=GLU:GLUTAMIC+ACID'>GLU</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.5Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1NG:1-{4-[2-OXO-2-(1-PYRROLIDINYL)ETHYL]PHENYL}-3-(+TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOLE'>1NG</scene>, <scene name='pdbligand=GLU:GLUTAMIC+ACID'>GLU</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2xxh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2xxh OCA], [https://pdbe.org/2xxh PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2xxh RCSB], [https://www.ebi.ac.uk/pdbsum/2xxh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2xxh ProSAT]</span></td></tr> |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
Line 15: | Line 16: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 2xxh" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
- | *[[ | + | *[[Glutamate receptor 3D structures|Glutamate receptor 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
[[Category: Rattus norvegicus]] | [[Category: Rattus norvegicus]] | ||
- | [[Category: Aldegheri | + | [[Category: Aldegheri L]] |
- | [[Category: Austin | + | [[Category: Austin NE]] |
- | [[Category: Ballantine | + | [[Category: Ballantine S]] |
- | [[Category: Ballini | + | [[Category: Ballini E]] |
- | [[Category: Bax | + | [[Category: Bax BD]] |
- | [[Category: Bradley | + | [[Category: Bradley DM]] |
- | [[Category: Clarke | + | [[Category: Clarke BP]] |
- | [[Category: | + | [[Category: DalNegro G]] |
- | [[Category: Harries | + | [[Category: Harries M]] |
- | [[Category: Harris | + | [[Category: Harris AJ]] |
- | [[Category: Harrison | + | [[Category: Harrison SA]] |
- | [[Category: Melarange | + | [[Category: Melarange RA]] |
- | [[Category: Mookherjee | + | [[Category: Mookherjee C]] |
- | [[Category: Mosley | + | [[Category: Mosley J]] |
- | [[Category: Oliosi | + | [[Category: Oliosi B]] |
- | [[Category: Smith | + | [[Category: Smith KJ]] |
- | [[Category: Thewlis | + | [[Category: Thewlis KM]] |
- | [[Category: Ward | + | [[Category: Ward SE]] |
- | [[Category: Woollard | + | [[Category: Woollard PM]] |
- | [[Category: Yusaf | + | [[Category: Yusaf SP]] |
- | + | ||
- | + | ||
- | + |
Current revision
Crystal structure of 1-(4-(2-oxo-2-(1-pyrrolidinyl)ethyl)phenyl)-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 1.5A resolution.
|
Categories: Large Structures | Rattus norvegicus | Aldegheri L | Austin NE | Ballantine S | Ballini E | Bax BD | Bradley DM | Clarke BP | DalNegro G | Harries M | Harris AJ | Harrison SA | Melarange RA | Mookherjee C | Mosley J | Oliosi B | Smith KJ | Thewlis KM | Ward SE | Woollard PM | Yusaf SP